Leaders from the biopharmaceutical industry, academia and government attend this conference to learn about the latest advances in the treatment of various types of pain and to network with colleagues from industry, academia, clinical research organizations, and government.
This conference provides attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products.
Industry Early Bird Rate: USD 1395.0,
Academic Early Bird Rate: USD 595.0
Speakers: Marta Sokolowska, Ph.D., Associate Director for Controlled Substances, Office of the Center Director, US FDA, Smriti Iyengar, Ph.D., Program Director, NINDS, Division of Translational Research, National Institutes of Health, Duncan Lascelles, Professor of Surgery and Pain Management, North Carolina State University College of Veterinary Medicine, Frank Sasinowski, MS, MPH, MD, Director Hyman, Phelps and McNamara, Paul Blahunka, PharmD., Sr. Director, Global Development Project Leader, Medical Specialties T.A., Astellas Pharma Global Development, Plus Many More